Aclaris Therapeutics, Inc. (ACRS)
3.97
-0.02
(-0.50%)
USD |
NASDAQ |
Oct 30, 16:00
3.965
0.00 (0.00%)
Pre-Market: 20:00
Aclaris Therapeutics Cash and Short Term Investments (Annual) : 90.75M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 90.75M |
| December 31, 2024 | 113.59M |
| December 31, 2023 | 119.11M |
| December 31, 2022 | 217.57M |
| December 31, 2021 | 191.41M |
| December 31, 2020 | 54.13M |
| December 31, 2019 | 75.02M |
| Date | Value |
|---|---|
| December 31, 2018 | 167.97M |
| December 31, 2017 | 193.86M |
| December 31, 2016 | 137.22M |
| December 31, 2015 | 84.87M |
| December 31, 2014 | 16.13M |
| December 31, 2013 | 13.32M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 372.15M |
| Alumis, Inc. | 308.58M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Veru, Inc. | 18.32M |
| Johnson & Johnson | 20.10B |